Desensitization in drug hypersensitivity;Desensibilisierung bei Uberempfindlichkeitsreaktionen auf Arzneimittel

Allergologie

Volumn 20, Issue 8, 1997, Pages 412-422

  Bircher, A J ^a,b  

^a Universitatsspital Basel Dermatologie   (Switzerland)

^b NONE   (Switzerland)

Author keywords

desensitization; drug allergy; drug hypersensitivity; rechallenge; review; tolerance; treating trough

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; COTRIMOXAZOLE; HORMONE; IMMUNOGLOBULIN E; PENICILLIN G; PEPTIDE; SULFONAMIDE; VACCINE;

ALLERGY TEST; DESENSITIZATION; DRUG HYPERSENSITIVITY; DRUG REEXPOSURE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; REVIEW; SKIN TEST;

EID: 0030824534     PISSN: 03445062     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (155)

1. Absar N., H. Daneshvar, G. Beall: Desensitization to trimethoprim/sulfamethoxazole in HIV-infected patients. J. Allergy Clin. Immunol. 93, 1001-1005 (1994).
2. Agardh C.D., B. Arner, S. Ekholm, E. Boijsen: Desensitization as a means of preventing untoward reactions to ionic contrast media. Acta Radiol. Diagn. 24, 235-239 (1983).
3. Al-Eryani A.Y., A.K. Al-Momen, D.F. Fayed, A.K. Allam: Successful heparin desensitization after heparin-induced anaphylactic shock. Thromb. Res. 79, 523-526 (1995).
4. Amedeo J., R.M. Chichimanian, B. Reboulot, H. Vinti, E. Rosenthal, A. Pesce, J.P. Cassuto: Désensibilisation des patients VIH positifs allergiques au cotrimoxazole. Thérapie 49, 463-465 (1994).
5. Anderson J A.: Allergic reactions to drugs and biological agents. JAMA 268, 2845-2857 (1992).
6. Anné S., E. Middleton, R.E. Reisman: Vancomycin anaphylaxis and successful desensitization. Ann. Allergy 73, 402-404 (1994).
7. Asad S.I., L.J.F. Youlten, M.H. Lessof: Specific desensitization in aspirin-sensitive urticaria, plasma prostaglandin levels and clinical manifestations. Clin. Allergy 13, 459-466 (1983).
8. Bacharier L.B., L.C. Schneider, F.J. Twarog: Antibiotic allergy and desensitization in a tertiary care pediatric hospital. J. Allergy Clin. Immunol. 99, S430 (1997).
9. Barbeau P., M. Pellegrin , J.L. Tunon de Lara, G. Brossard, A. Taytard, B. Leng: Désensibilisation aux beta-lactamines et à l'imipenem-cilastatine chez une patiente affecté d'une infection par le VIH. Rev. Med. Interne 12, 485 (1991).
10. Battersby N.C., L. Patel, T.J. David: Increasing dose regimen in children with reactions to ceftazidime. Clin. Exp. Allergy 25, 1211-1217 (1995).
11. Box D.E., R.S. Amos: Sulphasalazine in rheumatoid arthritis: desensitizing the patient with a skin rash. Ann. Rheum. Dis. 45, 139-140 (1986).
12. Belchí-Hernández J., F.J. Espinosa-Barra: Management of adverse reactions to prophylactic trimethoprim-sulfamethoxazole in patients with human immunodeficiency virus infection. Ann. Allergy. Asthma Immunol. 76, 355-358 (1996).
13. Berté S.J., J.D. DiMase, C.S. Christianson: Isoniazid, para-aminosalicylic acid and streptomycin intolerance in 1744 patients. Am. Rev. Respir. Dis. 90, 598-606 (1964).
14. Bircher A.J.: Arzneimittelallergie und Haut. Thieme, Stuttgart 1996.
15. Bircher A.J.: Stellenwert der in-vivo und in-vitro-Diagnostik bei kutanen Überempfindlichkeitsreaktionen auf Arzneimittel. Schweiz. Ärztezeitung 78, 782-786 (1997).
16. Bircher A.J., M. Rutishauser. Oral "desensitization" of maculopapular exanthema from ciprofloxacin in cystic fibrosis. Allergy, in press.
17. Bittleman D.B., J. Stapleton, T.B. Casale: Report of successful desensitization to itraconazole. J. Allergy Clin. Immunol. 94, 270-271 (1994).
18. Bodendorfer T.W., M.E. Brown, E.H. Frankel, B.H. Palay, S.R. Fulp: Desensitization with human (recombinant DNA) insulin. Drug Intell. Clin. Pharm. 19, 827-829 (1985).
19. Boggavarapu J., W.L. Smits, T.J. Craig: Desensitization to fluconazole. Annual Meeting American College 7 (1996).
20. Borish L., R. Tamir, L.J. Rosenwasser: Intravenous desensitization to beta-lactam antibiotics. J. Allergy Clin. Immunol. 80, 314-319 (1987).
21. Bouboulis D.A., A. Rubinstein, J. Shliozberg, J. Madden, M. Frieri: Cerebral toxoplasmosis in childhood and adult HIV infection treated with 1-4 hydroxynaphthoquinone and rapid desensitization with pyrimethamine. Ann. Allergy Asthma Immunol 74, 491-494 (1995).
22. Bousquet J., F. Maurice, J.P. Rivory, W. Skassa-Brociek, P. Florence, R. Chouzenoux, C. Mion, F.B. Michel: Allergy in long-term hemodialysis J. Allergy Clin. Immunol. 81, 605-610 (1988).
23. Branco-Ferreira M., M.H. Clode, M.A Pereira-Barbosa, A.G. Palma-Carlos: Anaphylactic reaction to hydroxycobalamin Allergy 52, 118-119 (1997).
24. Broome C.B., R.I. Schiff, H.S. Friedman: Successful desensitization to carboplatin in patients with systemic hypersensitivity reactions. Med. Pediatr. Oncol. 26, 105-110 (1996).
25. Brown L.A., N.D. Goldberg, W.T. Shearer: Long-term ticarcillin desensitization by the continuous oral administration of penicillin. J. Allergy Clin. Immunol. 69, 51-54 (1982).
26. Butchey J., H. Kim, D. Lloyd: A novel method of desensitization with Pentasa. J. Allergy Clin. Immunol. 99, S431 (1997).
27. Cabili S., Y. Shemer, M. Revach, M. Pras. Allergic reactions and desensitization to colchicine in familial Mediterranean fever. Rheumatologie 12, 207-208 (1982).
28. Cantani A., A. Serra, G. Arcese, P. Lucenti: Allergic reactions to MMR vaccines in egg-and non-egg-sensitive children: a continuing controversy. Pediatr. Asthma Allergy Immunol. 9, 7-14 (1995).
29. Carey A.B., E.O. Meltzer: Diagnosis and "desensitization" in tetanus vaccine hypersensitivity. Ann. Allergy 69, 336-338 (1992).
30. Carr A., R. Penny, D.A. Cooper: Allergy and desensitization to zidovudine in patients with acquired immunodeficiency syndrome (AIDS). J. Allergy Clin. Immunol. 91, 683-685 (1993).
31. Carr A., R. Penny, D.A. Cooper: Efficacy and safety of rechallenge with low-dose trimethoprim-sulphamethoxazole in previously hypersensitive HIV-infected patients. AIDS 7, 65-71 (1993).
32. Caumes E., G. Guermonprez, C. Lecomte, C. Katlama, F. Bricaire: Efficacy and safety of desensitization with sulfamethoxazole and trimethoprim in 48 previously hypersensitive patients infected with human immunodeficiency virus. Arch. Dermatol. 133, 465-469 (1997).
33. Caumes E., G. Guermonprez, C. Winter, C. Katlama, F. Bricaire: A life-threatening adverse reaction during trimethoprim-sulfamethoxazole desensitization in a previously hypersensitive patient infected with human immunodeficiency virus. Clin Infect. Dis. 23, 1313-1314 (1996).
34. Chan C.Y., A.L. Baker: Penicillamine hypersensitivity: Successful desensitization of a patient with severe hepatic Wilson's disease. Am. J. Gastroenterol. 89, 442-443 (1994).
35. Chandler M.J., R.C. Ong, L.C. Grammer, T.J. Sullivan: Detection, characterization, and desensitization of IgE to streptomycin. J. Allergy Clin. Immunol. 89, 178 (1992).
36. Charpin J., J. Aubert, P. Ohresser, C. Boutin, J.P. Roccasera: Allergie aux produits iodés de contraste. Possibilité de la désensibilisation spécifique. Mars. Med. 102, 569-571 (1965).
37. Chng H.H., K.P. Leong, K.C Loh: Primary systemic allergy to human insulin: recurrence of generalized urticaria after successful desensitization. Allergy 50, 984-987 (1995).
38. Cortese L.M., D.M. Soucy, T.P Endy: Trimethoprim/sulfamethoxazole desensitization. Ann. Pharmacother. 30, 184-186 (1996).
39. Craig T.J., F. Peralta, J. Boggavarapu: Desensitization for fluconazole hypersensitivity. J. Allergy. Clin. Immunol. 98, 845-846 (1996).
40. De la Hoz Caballer B., M. Fernandez Rivas, J. Fraj Lazaro, S. Quirce Gancedo, I. Davila Ruiz, J. Puyana Ruiz, J. Cuesta Herranz, E. Alvarez Cuesta, M. Cuevas, M.J. Perez Elias: Management of sulfadiazine allergy in patients with acquired immunodeficiency syndrome. J. Allergy Clin. Immunol. 88, 137-138 (1991).
41. De Weck A.: Prevention and treatment of drug allergies. In: de Weck A., H. Bundgaard: Allergic reactions to drugs. Handbook of experimental pharmacology. Springer, Berlin 1983, 227-240.
42. Di Marco J.N., A. Poujol, Y. Rimet, M.F. Fardeau, Y. Brusquet, R. Poirier: Accoutumance rapide pour la manifestation anaphylactoide à la desferrioxamine. Arch. Pediatr. 1, 959-961 (1994).
43. Dietrich D.A., Y. Kawabuko, B. Rzany, M. Mockenhaupt, J.C. Simon, E. Schöpf: Low N-acetylating capacity in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. Exp. Dermatol. 4, 313-316 (1995).
44. Donikyan R., A. Leblanc: Réaction anaphylactoide à la desferrioxamine. Arch. Pediatr. 2, 703 (1995).
45. Douglas D.M , L. Ward, J.S Brown: Nonsteroidal antiinflammatory drug desensitization using flurbiprofen (Ansaid). Ann. Allergy 71, 459-460 (1993)
46. Douglas R., D. Spelman, D. Czarny, R. O'Hehir: Desensitization to itraconazole. J. Allergy Clin. Immunol. 99, 269 (1997).
47. Duque S., J. de la Puente, F. Rodríguez, L. Fernández Pellón, E. Maqutera, J. Jerez: Zidovudine-related erythroderma and successful desensitization: case report. J. Allergy Clin. Immunol. 98, 234-235 (1996).
48. Eames P: Adverse reactions to carbamazepine managed by desensitisation. Lancet 1, 509-510 (1989).
49. Earl H.S., T.J. Sullivan: Acute desensitization of a patient with cystic fibrosis allergic to both beta-lactam and aminoglycoside antibiotics. J. Allergy Clin. Immunol. 79, 477-483 (1987).
50. Essayan D.M., A. Kagey Sobotka, P.J. Colarusso, L.M. Lichtenstein, R.F. Ozols, E.D. King: Successful parenteral desensitization to paclitaxel. J. Allergy Clin. Immunol. 97, 42-46 (1996).
51. Fam A.G., J. Lewtas, J. Stein, T.W. Paton: Desensitization to allopurinol in patients with gout and cutaneous reactions. Am. J. Med. 93, 299-302 (1992).
52. Finegold I.: Oral desensitization to trimethoprim-sulfamethoxazol in a patient with acquired immunodeficiency syndrome. J. Allergy Clin. Immunol. 78, 905-908 (1986).
53. Freigang B., T.P. Jadavji, D.W. Freigang: Lack of adverse reactions to measles, mumps, and rubella vaccine in egg-allergic children. Ann. Allergy 73, 486-488 (1994).
54. Friedman A., A. Al-Sabbagh, L. Santos, J. Fishman-Lobell, M. Polanski, M. Prabhu Das, S. Khoury, H. Weiner: Oral tolerance: a biologically relevant pathway to generate peripheral tolerance against external and self antigens. In: Granstein R: Mechanisms of immune regulation. Chem. Immunol. 58, 259-290 (1994).
55. Fröscher W., D. Kleinhans: Erfolgreiche Toleranzinduktion bei einer Epilepsiepatientin mit Phenobarbital-Allergie. Nervenarzt, im Druck.
56. Gea-Banacloche J.C., D.D. Metcalfe: Ciprofloxacin desensitization. J. Allergy Clin. Immunol. 97, 1426-1427 (1996).
57. Georgitis J.W., M.C. Browning, D. Steiner, W.B. Lorentz: Anaphylaxis and desensitization to the murine monoclonal antibody used for renal graft rejection. Ann. Allergy 66, 343-347 (1991).
58. Gluckstein D., J. Ruskin: Rapid oral desensitization to trimethoprim-sulfamemoxazole (TMP-SMZ): use in prophylaxis for Pneumocystis carinii pneumonia in patients with AIDS who were previously intolerant to TMP-SMZ. Clin. Infect. Dis. 20, 849-853 (1995).
59. Goldberg A., R. Confino-Cohen, A. Fishman, Y. Beyth, M. Altaras: A modified, prolonged desensitization protocol in carboplatin allergy. J. Allergy Clin. Immunol. 95, 841-843 (1996).
60. Gonzalez E., M.R. Stein, A.E. Suarez: Pyrimethamine desensitization for central nervous system toxoplasmosis. J. Allergy Clin. Immunol. 89, 177 (1992).
61. Gossain V.V., D.R. Rovner, K. Mohan: Systemic allergy to human (recombinant) insulin. Ann. Allergy 55, 116-118 (1985).
62. Greenberger P.A., R. Patterson: Management of drug allergy in patients with acquired immunodeficiency syndrome. J. Allergy Clin. Immunol. 79, 484-488 (1987).
63. Grzelewska-Rzymowska I., J. Roznlecki, M. Szmidt: Aspirin desensitization in patients with aspirin-induced urticaria and angioedema. Allergol. Immunopathol. 76, 305-308 (1988).
64. Harper J.L., J.C. Gill, R.J. Hopp, J Evans, W.D. Haire: Induction of immune tolerance in a 7-year-old hemophiliac with an anaphylactoid reaction. Thromb. Hemostas. 74, 1039-1041 (1995).
65. Hasche H., W Bachmann, M. Haslbeck, H. Mehnert: Intrakutane Desensibilisierung von Patienten mit generalisierten Hautreaktionen bei Insulinbehandlung. Akt. Endokrin. Stoffw. 6, 129-132 (1985).
66. Henry R.E., J.A. Wegmann, J E Hartle, G.W. Christopher: Successful oral acyclovir desensitization. Ann. Allergy 70, 386-388 (1993).
67. Herman J.J., R. Radin: Allergic reactions to measles (rubeola) vaccine in patients hypersensitive to egg protein. J. Pediatr. 102, 196-199 (1983).
68. Hermle L., M. Spitzer: Erfolgreiche Hyposensibilisierungsbehandlung bei einem Patienten mit einer schizoaffektiven Psychose und Carbamazepinallergie. Nervenarzt 64, 208-210 (1993).
69. Holdaway I.M., J.D. Wilson: Cutaneous insulin allergy responsive to oral desensitisation and aspirin. Br. Med. J. 289, 1565-1566 (1984).
70. Holland C L., C. Malasky, A. Ogunkoya, L. Bielory: Rapid oral desensitization to isoniazid and rifampin. Chest 98, 1518-1519 (1990)
71. Huang S.W.: A clinical approach to a patient with praziquantel hypersensitivity. J. Allergy. Clin Immunol. 90, 867 (1992).
72. Hughes T.E., J.D. Almgren, R.W. McGuffin, R.J. Omoto: Co-trimoxazole desensitization in bone marrow transplantation. Ann. Intern. Med. 105, 148 (1986).
73. James J.M., A. Wesley Burks, P.K. Roberson, H.A. Sampson: Safe administration of the measles vaccine to children allergic to eggs. N. Engl. J. Med. 332, 1262-1266 (1995).
74. Johnson M.P., S.D. Goodwin, J.W. Shands: Trimethoprim-sulfamethoxazole anaphylactoid reactions in patients with AIDS: case reports and literature review. Pharmacotherapy 10, 413-416 (1990).
75. Jung A.C., D.S. Paauw: Management of adverse reactions to trimethoprim-sulfamethoxazole in human immunodeficiency virus-infected patients. Arch. Int. Med. 154, 2402-2406 (1994).
76. Kalanadhabhatta V., D. Muppidi, H. Sahni, A. Robles, M. Kramer: Successful oral desensitization to trimethoprim-sulfamethoxazole in acquired immune deficiency syndrome. Ann. Allergy Asthma. Immunol. 77, 394-400 (1996).
77. Kaplan B.Z., U. Krishnamurthy, D. Nori: Opiate desensitization in a terminally ill cancer patient with pain: physician assisted succor. Am. J. Hosp. Palliative Care 11, 34-39 (1994).
78. Kelly J.W., D.P. Dooley, C.P. Lattuada, C.E. Smith: A severe unusual reaction to trimethoprim-sulfamethoxazole in patients infected with human immunodeficiency virus. Clin. Infect. Dis. 14, 1034-1039 (1992).
79. Kelsey S.M., G.R. Struthers, T. Beswick, D.R. Blake: Desensitisation to allopurinol. Ann. Rheum. Dis. 46, 84-87 (1987).
80. Kelso J.M., R.M. Keating: Successful desensitization for treatment of a fixed drug eruption to allopurinol. J. Allergy Clin. Immunol. 97, 1171-1172 (1996).
81. Kletz M.R., C.L. Holland, J.S. Mendelson, L. Bielory: Administration of egg-derived vaccines in patients with a history of egg sensitivity. Ann. Allergy 64, 527-529 (1990).
82. Kletzel M., S. Beck, J. Elser, N. Shock, W. Burks: Trimethoprim-sulfamethoxazole oral desensitization in hemophiliacs infected with human immunodeficiency virus with a history of hypersensitivity reactions. Am. J. Dis. Child. 145, 1428-1429 (1991).
83. Korelitz B.I., D.H. Present, P.H. Rubin, S.E. Fochios: Desensitization to sulfosalazine after hypersensitivity reactions in patients with inflammatory bowel disease. J. Clin. Gastroenterol. 6, 27-31 (1984).
84. Koski J.M.: Desensitization to sulphasalazine in patients with arthritis. Clin. Exp. Rheumatol. 11, 169-170 (1993).
85. Kreuz W., T. Güngör, C. Lotz, M. Funk, B. Kornhuber: "Treating through" hypersensitivity to cotrimoxazole in children with HIV infection. Lancet 336, 508-509 (1990).
86. Kummerle-Deschner J., G. Dannecker: Sulphasalazine desensitization in a paediatric patient with juvenile chronic arthritis. Acta Paediatr. 84, 952-954 (1995).
87. Kurohara M.L., F.K. Kwong, T.B. Lebherz, W.B. Klaustermeyer: Metronidazole hypersensitivity and oral desensitization. J. Allergy Clin. Immunol. 88, 279-280 (1991).
88. La Rosa M., M.A. Romeo, F. Di Gregorio, G. Russo: Desensitization treatment for anaphylactoid reactions to desferrioxamine in a pediatric patient with thalassemia. J. Allergy Clin. Immunol. 97, 127-128 (1996).
89. Lachaux A., C. Le Gall, I. Loras Duclaux, A. Aboufadel, M. Hermier: Hypersensibilité à l'acide 5-aminosalicylique: interêt de la désensibilisation par voie orale. Arch. Pediatr. 4, 144-146 (1997).
90. Lang D.M.: Anaphylactoid and anaphylactic reactions. Hazards of β-blockers. Drug Saf. 12, 299-304 (1995).
91. Lantner R.R.: Ciprofloxacin desensitization in a patient with cystic fibrosis. J. Allergy Clin. Immunol. 96, 1001-1002 (1995).
92. Lauter C.B., T. Haver, A. Davidson: Pruritus and urticaria due to lamivudine (3TC, Epivir): allergic evaluation of a patient on combination therapy and successful oral "rush" desensitization. J. Allergy Clin. Immunol. 99, S433 (1997).
93. Lavi S., B. Zimmerman, G. Koren, R. Gold: Administration of measles, mumps, and rubella virus vaccine (live) to egg-allergic children. JAMA 263, 269-271 (1990).
94. Lehmann D.F., P.D. Holohan, D.C. Blair. Comparisons of oxidative metabolism and reductive capacity in sulfonamide-tolerant and -intolerant patients with human immunodeficiency virus. J. Clin. Pharmacol. 36, 1149-1153 (1996).
95. Leznoff A., K. E. Binkley, R.T. Joffee, A. Levitt, M.A. Richter: Adverse cutaneous reactions associated with fluoxetine strategy for reintroduction of this drug in selected patients. J. Clin. Psychopharmacol. 12, 355-357 (1992).
96. Lin R.Y.: Desensitization in the management of vancomycin hypersensitivity. Arch. Intern. Med. 150, 2197-2218 (1990).
97. Lombardo T. G. Ferro, V. Frontini, S. Percolla: High-dose intravenous desferrioxamine (DFO) delivery in four thalassemic patients allergic to subcutaneous DFO administration. Am. J. Hematol. 51, 90-92 (1996).
98. Loria R.C., N. Finnerty, H.J. Wedner: Successful use of aztreonam in a patient who failed oral penicillin desensitization. J. Allergy Clin. Immunol. 83, 735-737 (1989).
99. Loria R.C., S. Jadidi, J.E. Wedner: Anaphylactic reaction to ampicillin in a patient with common variable immunodeficiency syndrome desensitized to penicillin. Ann. Allergy 59, 15-16, 34-38 (1987).
100. Luka R.E., L.V. Centeno, R.E. Reyes, L. Bielory: Rapid oral desensitization to allopurinol. J. Allergy Clin. Immunol. 99, S432 (1997).
101. Maloney M.J., C.T. Stafford, D.M. Jamieson: Successful desensitization to factor VIII in a patient with classic hemophilia. J. Allergy Clin. Immunol. 75, 210 (1985).
102. Marcos C., B. Sopena, I. Luna, R. Gonzalez, J. De la Fuente, C. Martinez Vazquez: Clindamycin desensitization in an AIDS patient. AIDS 9, 1201-1202 (1995).
103. Máspero J.F., M.K. Kohan, A. Yáñez: Interferon alpha: anaphyalctic reaction and desensitization. J. Allergy Clin. Immunol. 99, S493 (1997).
104. Matz J., L.C. Borish, J.M. Routes, L.J. Rosenwasser: Oral desensitization to rifampin and ethambutol in mycobacterial disease. Am. J. Respir. Crit. Care Med. 149, 815-817 (1994).
105. Metroka C.E., N.J. Lewis: Desensitization to dapsone in HIV-positive patients. JAMA 22, 512 (1992).
106. Miller K.B., L.J. Rosenwasser, J.A. Bessette, D.J. Beer, R.E. Rocklin: Rapid desensitisation for desferrioxamine anaphylactic reaction. Lancet 1, 1059 (1981).
107. Monaghan M.S., G. Glasco, G.S.T. John, R.W. Bradsher, K.M. Olsen: Safe administration of iron dextran to a patient who reacted to the test dose. South Med. J. 87, 1010-1012 (1994).
108. Moreno J.N., R.B. Poblete, C. Maggio, S. Gagnon, M.A. Fischl: Rapid oral desensitization for sulfonamides in patients with the acquired immunodeficiency syndrome. Ann. Allergy Asthma Immunol. 74, 140-146 (1995).
109. Murphy K.R., R C. Strunk: Safe administration of influenza vaccine in asthmatic children hypersensitive to egg proteins. J Pediatr. 106, 931-933 (1985).
110. Nagel C., M. Talaulicar, I. Humbert, B. Willms: Allergie gegen Humaninsulin. Dtsch. Med. Wochenschr. 113, 1013-1016 (1988).
111. Nataf P., J. Dry: Une méthode thérapeutique au cours des allergies médicamenteuses: l'accoutumance. Sem. Hop. 52, 1703-1704 (1976).
112. Nguyen B.Y., D.L. Landucci, R.E. Cunnion, R. Yarchoan, R.E. Walker: A case of hyperdynamic shock caused by trimethoprim-sulfamethoxazole in which no tumor necrosis factor or features of anaphylaxis were detected. Clin. Infect. Dis. 17, 885-887 (1993).
113. Nguyen M.T., P.J. Weiss, M.R. Wallace: Two-day oral desensitization to trimethoprim-sulfamethoxazole in HIV-infected patients. AIDS 9, 573-575 (1995).
114. Palusci V.J., A. Kaul, R.M. Lawrence, K.A. Haines, P.L. Kwittken: Rapid oral desensitization to trimethoprim-sulfamethoxazole in infants and children. Pediatr. Infect. Dis. J. 15, 456-460 (1996).
115. Papakonstantinou G., J R. Bogner, F Hofineister, R. Hehlmann: Cefotaxime desensitization. Clin. Invest. 71, 165-167 (1993).
116. Papakonstantinou G., H. Füessl, R. Hehlmann: Trimethoprim-sulfamethoxazole desensitization in AIDS. Klin. Wochenschr. 66, 351-353 (1988).
117. Park B.K., N.R. Kitteringham, M. Pirmohamed, G.T. Tucker: Relevance of induction of human drug-metabolizing enzymes: Pharmacological and toxicological implications. Br. J. Clin. Pharmacol. 41, 477-491 (1996).
118. Patriarca G., M. Rossi, D. Schiavino, G. Schinco, G. Fais, C. Varano, R. Schiavello: Rush desensitization in heparin hypersensitivity: a case report. Allergy 49, 292-294 (1994).
119. Patriarca G., A. Venuti, D. Schiavino: Desensitizing treatment in allergy to synthetic corticotrophin: study of three cases. Acta Allergol. 29, 469-473 (1974).
120. Patterson R., R.D. deSwarte, P.A. Greenberger, L.C Grammer: Drug allergy and protocols for management of drug allergies. NER Allergy Proc. 7, 325-342 (1986).
121. Patterson R., R.D. deSwarte, P.A. Greenberger, L.C. Grammer, J.E. Brown, C.A. Choy: Drug allergy and protocols for management of drug allergies. Allergy Proc. 15, 239-264 (1994).
122. Piketty C., J. Gilquin, M.D. Kazatchkine: Accoutumance au triméthoprime-sulfaméthoxazole chez les malades infectés par le VIH. Ann. Med. Interne 147, 327-330 (1996).
123. Purdy B.H., D.M. Philips, R.W. Summers: Desensitization for sulfasalazine skin rash. Ann. Intern. Med. 100, 512-514 (1984).
124. Purves S.J., S.A. Hashimoto, K.A. Tse: Successful desensitization of patients with carbamazepine allergy. Can. J. Neurol. Sci. 15, 237 (1988).
125. Putterman C., G. Rahav, M. Shalit, A. Rubinow: "Treating through" hypersensitivity to cotrimoxazole in AIDS patients. Lancet 336, 52 (1990).
126. Roujeau J.C., R.S. Stern: Severe adverse cutaneous reactions to drugs. N. Engl. J. Med. 331, 1272-1285 (1994).
127. Schydlowsky P.: Salazopyrin-desensibilisering. Ugeskr. Laeger 155, 476-478 (1993).
128. Shafer R.W., P.A. Seitzman, M.L. Tapper: Successful prophylaxis of Pneumocystis carinii pneumonia with trimethoprim-sulfamethoxazole in AIDS patients with previous allergic reactions. J. AIDS 2, 389-393 (1989).
129. Sheffer A.L., D.S. Pennoyer: Management of adverse drug reactions. J. Allergy Clin. Immunol. 74, 580-588 (1984).
130. Sher M.R., C. Suchar, R.F. Lockey: Anaphylactic shock induced by oral desensitization to trimethoprim-sulfmethoxazole. J. Allergy Clin. Immunol. 77, 133 (1986).
131. Sjövall P., O.B. Christensen: Oral hyposensitization in allergic contact dermatitis. Semin. Dermatol. 9, 206-209 (1990).
132. Smith H., R. Newton: Adverse reactions to carbamazepine managed by desensitization. Lancet 1, 753 (1985).
133. Stark B.J., H.S. Earl, G.N. Gross, W.R. Lumry, E.L. Goodman, T.J. Sullivan: Acute and chronic desensitization of penicillin-allergic patients using oral penicillin. J. Allergy Clin. Immunol. 79, 523-532 (1987).
134. Steinberg D.G., L.C. Borish, L.J. Rosenwasser, B.A.E. Walz-LeBlanc, D.K. MacFadden, W.J. Reynolds: Pharmacologic desensitization by intravenous protocols. Arthritis Rheum. 35, 842-843 (1992).
135. Stevenson D.D., M.A. Hankammer, D.A. Mathison, S.C. Christiansen, R.A. Simon: Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: Long-term outcomes. J. Allergy Clin Immunol. 98, 751-758 (1996).
136. Stricker R.B., J.H. Gullett, L.E. Williams, B. Goldberg: Co-trimoxazole desensitization syndrome: Delayed hematologic toxicity complicating prophylactic therapy in AIDS patients. AIDS 10, 927-929 (1996).
137. Sullivan T.J.: Antigen-specific desensitization of patients allergic to penicillins. J. Allergy Clin. Immunol. 69, 500-508 (1982).
138. Sullivan T.J.: Antigen-specific desensitization to prevent allergic reactions to drugs. Ann. Allergy 73, 375-377 (1994).
139. Sullivan T.J., L.D. Yecies, G.S. Shatz, C.W. Parker, H.J. Wedner: Desensitization of patients allergic to penicillin using orally administered beta-lactam antibiotics. J. Allergy Clin. Immunol 69, 275-282 (1982).
140. Tadokoro K., N. Niimi, T. Ohtoshi, K. Nakajima, S. Takafuji, K. Onodera, S. Suzuki, M. Murunaka: Cefotiam-induced IgE-mediated occupational contact anaphylaxis of nurses, case reports. RAST analysis, and a review of the literature. Clin. Exp. Allergy 24, 127-133 (1994).
141. Tenant-Flowers M., M.J. Boyle, D. Carey, D.J. Marriott, J.L. Harkness, R. Penny, D.A. Cooper: Sulphadiazine desensitization in patients with AIDS and cerebral toxoplasmosis. AIDS 5, 311-315 (1991).
142. Ter Schiphorst C., J Bousquet, J.L. Menardo, M. Piquemal, A. Bataille, F.B. Michel: Désensibilisation spécifique au cis-dichlorodiamino-platinum (DDP) chez un malade allergique. Presse Med. 15, 1242 (1986).
143. Thomas H., J.J. Eledjam, M. Macheboeuf, F. d'Athis, P. Mares, J. Bousquet: Rapid pre-operative immunotherapy in a patient allergic to muscle relaxants. Eur. J. Anaesthesiol. 5, 385-389 (1988).
144. Thompson D.M., J.J. Ronco: Prolonged desensitization required for treatment of generalized allergy to human insulin. Diabetes Care 16, 957-958 (1993).
145. Tolia V.: Sulfasalazine desensitization in children and adolescents with chronic inflammatory bowel disease. Am. J. Gastroenterol. 87, 1029-1032 (1992).
146. Trotter A.C., B.D. Stone, D.J. Laszlo, J.W. Georgitis: Measles, mumps, rubella vaccine administration in egg-sensitive children: Systemic reactions during vaccine desensitization. Ann. Allergy 72, 25-28 (1994).
147. Walker S.B., M.E. Weiss, D.S. Tattoni: Systemic reaction to human growth hormone treated with acute desensitization. Pediatrics 90, 108-109 (1992).
148. Walz-LeBlanc B.A., W.J. Reynolds, D.K. MacFadden: Allopurinol sensitivity in a patient with chronic tophaceous gout: success of intravenous desensitization after failure of oral desensitization. Arthritis Rheum. 34, 1329-1331 (1991).
149. Watts D., J. Bird: Oxcarbazepine sensitivity treated by desensitisation. J. Neurol. Neurosurg. Psychiatry 54, 376 (1991).
150. Wendel G.D. Jr., B.J. Stark, R.B. Jamison, R.D. Molina, T.J. Sullivan: Penicillin allergy and desensitization in serious infections during pregnancy. N. Engl. J. Med. 312, 1229-1232 (1985).
151. White M.V., Z.H. Haddad, E Brunner, C. Sainz: Desensitization to trimethoprim sulfamethoxazole in patients with acquired immune deficiency syndrome and Pneumocystis carinii pneumonia. Ann. Allergy 62, 177-179 (1989).
152. Windom H.H., W.P. McGuire, R.G. Hamilton, N F. Adkinson Jr.: Anaphylaxis to carboplatin - a new platinum chemotherapeutic agent. J. Allergy Clin. Immunol. 90, 681-683 (1992).
153. Wolkenstein P., V. Carrière, D. Charue, S. Bastuji-Garin, J. Revuz, J.C. Roujeau, P. Beaune, M. Bagot: A slow acetylator genotype is a risk factor for sulphonamide-induced toxic epidermal necrolysis and Stevens-Johnson syndrome. Pharmacogenetics 5, 255-258 (1995).
154. Wong J.T., R.E. Ripple, J.A. MacLean, D.R. Marks, K.J. Bloch: Vancomycin hypersensitivity: synergism with narcotics and "desensitization" by a rapid continuous intravenous protocol. J. Allergy Clin. Immunol 94, 189-194 (1994).
155. Young M.C., D. Wooten: Rho (D) immune globulin (RDIg) hypersensitivity and desensitization. J. Allergy Clin. Immunol. 99, S432 (1997).